“We are so impressed with your serious scientific discussion, professional advice, and excellent service. We would like to commission many experiments with our other pipeline in the future, and I promise to introduce Gifford to many other groups. Thanks to all of you!”

Principal Researcher, Korean Biotech, Feb 2021

“I am really impressed how fast and professionally you act. 😊. It is clear to me that you at Gifford like ‘doing science’ and challenges.”

Principal Scientist, German Pharma, Jan 2021

Two-thirds of our business is repeat business, coming from scientists we have worked with before.

(2019/20)

“Thank you very much for the reliable and professional collaboration. It was a pleasure working with Gifford. Further collaboration using rat spinal chord sections are, therefore, definitely an option.”

Preclinical Research Manager, German Pharma, Jan 2020

“If I haven’t told you before – you are all truly wonderful. Thank you sincerely for your ongoing support and collaboration.”

VP of Drug Development, Australian Biotech, Nov 2019

An international customer base:

54% of our clients are from the USA, 26% from Europe, 20% from Asia/Pacific.

(2019/20)

“K_D determination of drug binding to targets, by equilibrium and kinetic measurements, is an essential component of our mechanism of action analyses for drug development. Gifford Bioscience performs this service using radionuclides with the highest quality, in a cost effective and timely manner.”

Director of Biology, Californian Biotech, June 2019